首页> 美国卫生研究院文献>Infection and Immunity >A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria.
【2h】

A strong antibody response to the periplasmic C-terminal domain of the OmpA protein of Escherichia coli is produced by immunization with purified OmpA or with whole E. coli or Salmonella typhimurium bacteria.

机译:通过用纯化的OmpA或完整的大肠杆菌或鼠伤寒沙门氏菌进行免疫可产生对大肠杆菌OmpA蛋白周质C末端结构域的强抗体反应。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We produced in Bacillus subtilis the complete, as well as the N-terminal two-thirds, OmpA protein of Escherichia coli (called here Bac-OmpA and Bac-OmpA-dN, respectively). These Bac-OmpA proteins were used to examine the immunological properties of different parts of OmpA, free of lipopolysaccharide and other components of the outer membrane. The full-length Bac-OmpA was indistinguishable from the authentic protein isolated from E. coli (Coli-OmpA) both as immunogen and as antigen in enzyme immunoassay (EIA). The N-terminal Bac-OmpA-dN was a poor immunogen which gave rise to significantly lower titers of anti-OmpA antibody than did the full-length OmpA preparations. When used as an antigen in EIA, the Bac-OmpA-dN detected anti-OmpA antibody in serum samples from animals immunized with the full-length OmpA much less efficiently than did either Bac-OmpA or Coli-OmpA. The periplasmic C-terminal domain therefore appears to be an immunodominant epitope of the purified OmpA protein. Also, when rabbits and mice were immunized with intact, live or dead E. coli, the antibody response detected by EIA with the full-length protein, Bac-OmpA, was much stronger than that detected with the N-terminal two-thirds, Bac-OmpA-dN. Similar results were obtained with the OmpA of Salmonella typhimurium. Because the ompA gene of enterobacteria is highly conserved, the Bac-OmpA might be useful as a group-specific EIA antigen to diagnose diseases caused by members of the family Enterobacteriaceae.
机译:我们在枯草芽孢杆菌中生产了大肠杆菌的完整以及N末端三分之二的OmpA蛋白(分别称为Bac-OmpA和Bac-OmpA-dN)。这些Bac-OmpA蛋白用于检查OmpA不同部分的免疫学特性,不含脂多糖和外膜的其他成分。全长Bac-OmpA与从大肠杆菌分离的真实蛋白(Coli-OmpA)在酶免疫测定(EIA)中既是免疫原又是抗原没有区别。 N末端Bac-OmpA-dN的免疫原性较差,与全长OmpA制剂相比,产生的抗OmpA抗体效价明显更低。当在EIA中用作抗原时,Bac-OmpA-dN在用全长OmpA免疫的动物的血清样品中检测到抗OmpA抗体的效率要比Bac-OmpA或Coli-OmpA低得多。因此,周质C端结构域似乎是纯化的OmpA蛋白的免疫优势表位。同样,当兔和小鼠用完整的,活的或死的大肠杆菌进行免疫时,EIA用全长蛋白Bac-OmpA检测到的抗体应答要强于三分之二的N端检测到的抗体应答, Bac-OmpA-dN。用鼠伤寒沙门氏菌的OmpA获得了相似的结果。因为肠杆菌的ompA基因是高度保守的,所以Bac-OmpA可用作特定于群体的EIA抗原,以诊断由肠杆菌科成员引起的疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号